Le Lézard
Classified in: Health
Subject: PDT

CareNu Subsidiary SECUR Receives HMO License


SECUR's Medicare Advantage special needs plan will enable CareNu to better serve individuals with advanced chronic illness

TAMPA, Fla., April 25, 2024 /PRNewswire/ -- CareNu, a data-forward healthcare organization using predictive analytics to revolutionize care for the medically vulnerable, announced that its subsidiary, SECUR, obtained a Healthcare Maintenance Organization (HMO) license to pursue its goal of launching a Medicare Advantage Institutional Special Needs Plan (I-SNP). This expansion marks a significant milestone for CareNu and will allow the organization to continue revolutionizing healthcare for individuals with complex needs and advanced chronic illness.

"CareNu's SECUR embodies our mission to be a lifeline for individuals battling complex chronic illness, offering a level of care and support unparalleled in the industry," said Paola Bianchi Delp, president of CareNu. "In launching SECUR, we are building on the success of the other innovative service lines in our portfolio, which bring agility, customer service and personal engagement to patients and providers every day. Our innovative solutions continue to prove our commitment to pioneering advancements that redefine standards of care."

"Since its founding, CareNu has driven the evolution of chronic care illness management in the nation, achieving groundbreaking improvements in health outcomes," said Andrew Molosky, CareNu CEO and Chapters Health System CEO. "By leveraging cutting-edge analytics, population health analysis and social determinants of health surveys, CareNu ensures each member receives personalized care that addresses their unique needs."

The new plan will emulate CareNu's other successful programs, which coordinate chronic illness care for over 5,000 people. Through ASSURITY DCE, the organization has revolutionized care for more than 2,000 patients. From 2021 to 2023, the program saw a 52-percent reduction in emergency room visits and a 61-percent reduction in hospitalizations, as a result of its commitment to comprehensive, preventative care.

To learn more about SECUR, visit www.securhealthplan.com.

About CareNu

CareNu is a data-forward healthcare organization using predictive analytics to revolutionize care for the medically vulnerable and their families. CareNu is at the forefront of a new healthcare approach in America by leveraging data and resources to optimize the patient experience and care delivery model. The organization also operates several at-home primary care entities, a health plan and numerous global risk initiatives. It operates on a value-based care model and encompasses the entire health ecosystem for chronic illness care. CareNu is a subsidiary of Chapters Health System, a collective of advanced illness companies including 10 hospices, behavioral health services, PACE centers and a pharmacy company. CareNu embraces innovation to transform the patient-family experience. To discover the future of healthcare, visit www.carenu.com.

SOURCE CareNu


These press releases may also interest you

at 18:42
George Weston Limited ("Weston" or the "Company") today announced that all of the nominee directors listed in its management proxy circular dated March 19, 2024, were elected as directors of the Company. The vote was conducted at the Company's...

at 18:41
Family Source Consultants, LLC, a leading provider of surrogacy, egg donation, and all third-party reproduction services, is excited to announce the grand opening of its new state-of-the-art office dedicated to enhancing the journeys of intended...

at 18:15
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024....

at 18:00
In recognition of Mother's Day on May 12th, Denny's Canada is delighted to announce that they have partnered with Women's Health Collective Canada (WHCC) to host a special fundraiser. From May 7th to 12th, in participating stores across Canada, $2...

at 17:41
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial...

at 17:09
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for...



News published on and distributed by: